# Session Handoff

## Current State

The project is a working Streamlit dashboard that writes market, news, report, validation, and history artifacts under `output/`.

The current documented live baseline is:

- Date: 2026-07-26 13:34 UTC
- Stance: Neutral
- Health Stack Flywheel Score: 59.0
- LLY AI trade score: 66.8
- Ticker rows: 38
- Accepted stories: 77
- Qualified scoring stories: 24
- Market data quality: High
- RSS errors: 0
- Tests: 38 passing (pre-Phase-1 baseline)

## Phase 1 Status (2026-10-11)

Phase 1 is complete as of 2026-10-11. Adversarial review findings were fixed, live Windows validation passed, and the implementation was approved for merge to `master`.

What was built (per the operator's 2026-10-11 decisions):

- Eight sleeves per the approved rosters; AI Infrastructure Enablers (NVDA, TSM, AVGO, SMH, SOXX) kept as a supporting eighth sleeve — explicit classifier input, reported, but excluded from core health-stack breadth counts.
- `config/health_stack_sleeves.yaml` + loud-validation loader (`glp1_watch/health_stack_sleeves.py`).
- Sleeve summaries + leadership concentration (`glp1_watch/leadership_concentration.py`).
- Precedence-ordered eight-state confirmation classifier + leader/stack assessments (`glp1_watch/confirmation_state.py`).
- Heuristic news-event clustering (`glp1_watch/news_event_clustering.py`).
- Pipeline wiring, `Health Stack Confirmation Structure` report section, Streamlit expander.
- 57 new tests, all passing. Full suite: 91 passed, 4 failed — the 4 failures are pre-existing `test_news.py` date-window artifacts (fail on master too).
- Documented Phase 1 limitations: two-name Health Data and Clinical AI sleeve; heuristic clustering.

Phase 1 completion checks:

1. ~~Adversarial review~~ done 2026-10-11; findings fixed on the branch:
   - Real fuzzy event clustering (theme + ticker overlap + title Jaccard >= 0.3 + 72h window).
   - `qualified_theme_count` / `news_top_ticker_share` wired into the classifier as downward-only constraints.
   - AI Infrastructure Enablers as an explicit classifier input (blocks Broadly Confirming when deteriorating; never upgrades).
2. ~~Live validation run~~ done 2026-10-11 on Windows after the clustering fix: 85 accepted stories produced 83 unique events, including one multi-source event.
3. ~~Operator merge approval~~ received 2026-10-11.

## Phase 1 Merge (2026-10-11)

Codex merged PR #1 to `master` 2026-10-11; the merge was verified byte-identical to the reviewed branch (all seven Phase 1 code files).

## Phase 2 Status (2026-10-11)

Phase 2 was approved 2026-10-11 and implemented on branch `muse/phase-2-opportunity-scoring`.

What was built:

- `config/decision_weights.yaml` + loud-validating loader (`glp1_watch/decision_weights.py`): opportunity weights 0.35/0.25/0.20/0.20, interpretation bands, catalyst saturation, trend and recognition-gap thresholds.
- Per-sleeve Structural Thesis Score (`glp1_watch/structural_thesis.py`): news-evidence proxy, Bayesian-smoothed to 50-neutral with no data.
- Per-sleeve Market Confirmation Score (`glp1_watch/market_confirmation.py`): returns, RS breadth, trend position, drawdown, momentum pace, volatility, concentration.
- Per-sleeve Catalyst Score (`glp1_watch/catalyst_score.py`): unique material events across six categories, sentiment-signed, per-category saturation.
- Per-sleeve Expectations Risk Score (`glp1_watch/expectations_risk.py`): confidence capped at Medium (no valuation data).
- Per-sleeve Opportunity Scores + six trend labels + recognition-gap flags (`glp1_watch/opportunity.py`).
- Overall score renamed to Health Stack Flywheel Score in report/dashboard labels (`overall_score` key unchanged).
- `Health Stack Opportunity Ranking` report section + Streamlit expander.
- 42 new tests, all passing. Full suite: 133 passed, 4 failed — the 4 failures are the pre-existing `test_news.py` date-window artifacts (fail on master too).

Operator decisions applied (Codex out of tokens; Muse decided per operator instruction):

- Structural Thesis as news-evidence proxy, labeled honestly.
- Default weights as proposed in YAML (tunable later).
- AI Infrastructure Enablers included in the ranking, flagged `(supporting)`.
- Theme→catalyst mapping as proposed (M&A theme feeds both partnership and m&a).

Phase 2 completion checks:

1. ~~Adversarial review~~ done 2026-10-11 (separate agent, empirical — executed the branch code): 0 critical, 2 major, 11 minor. Fixed on the branch:
   - M1: all-NaN RS columns skip `rs_breadth` instead of fabricating 0.0 (benchmark-outage guard, same bug class as the Phase 1 classifier fix).
   - M2: `opportunity_weights` requires the exact four keys; unknown/boolean keys rejected at load (no more KeyError crash on degenerate configs).
   - Minors: zero-weight-sum → no score (not crash); `interpret_opportunity(NaN)` → "Insufficient data"; recognition-gap thresholds range-checked; `structural_thesis` tolerates missing `tickers` column; trend labels stay in the closed six-label set; opportunity confidence tops out at Medium; catalyst confidence counts signed events only; added strong-stack/weak-leader and high-dispersion tests.
   - Verified correct: rosters/TICKER_GROUPS byte-identical to master; all score bounds hold; no silent blending; rename preserves history compat; report renders n/a cleanly; spec honesty rules kept.
2. ~~Live validation run~~ done 2026-10-11 (Linux, real market + news data): `generate_snapshot.py` completed (stance Neutral, flywheel 42.8); Opportunity Ranking rendered all eight sleeves plausibly (Health Data and Clinical AI 59.3 first; Gene Editing 38.9 last; no recognition gaps). Caught and fixed one live-only bug: ticker `KeyError` on comma-space lists in `expectations_risk.py` (+ regression test). A confirmatory run on the operator's Windows machine is still welcome but no longer blocking.
3. Operator merge approval — pending.

## Phase 3 Status (2026-10-11)

Phase 3 was approved 2026-10-11 and implemented on branch `muse/phase-3-persistence-readiness`.

What was built:

- `glp1_watch/persistence_engine.py`: history store, persistence metrics, seven-state readiness classification, what-changed diffing.
- `## Persistence and Decision Readiness` and `## What Changed Since the Previous Report` report sections + Streamlit expander.
- 19 new tests, all passing.

Operator decisions applied (per standing instruction to decide and document):

- CSV store at `output/history/health_stack_history.csv` (spec allows CSV or SQLite; CSV matches project conventions).
- Upsert on (as_of_date, sleeve); improvement = delta >= 1.0 point; strong/weak cutoffs reuse decision weights (65/45).
- Readiness precedence: Insufficient Evidence → Repairing → Exhausted → Persistent → Confirmed → Developing → Early Signal; Exhausted outranks Persistent by design.
- Conflicting evidence always reported alongside the classification.
- History starts cold (no backfill possible); early runs read Insufficient Evidence until streaks form.

Phase 3 completion checks:

1. ~~Adversarial review~~ done 2026-10-11 (separate agent, empirical): 0 critical, 3 major, 8 minor. Fixed on the branch:
   - M1: atomic history writes (temp + rename).
   - M2: history only written when outputs are written (dry-run pollution fixed).
   - M3: second derivative treats sub-noise-floor delta differences as steady.
   - Minors: deterioration fallthrough note corrected; Exhausted uses direct breadth_50dma with <= 0 gate; future dates rejected; sleeve-rename streak behavior documented; section renamed to "Flywheel Score: Change Since Prior Run"; `condition` field names the winning streak.
   - Verified correct: all 13 spec test items genuinely covered; all 7 readiness states reachable with spec examples holding; precedence total and correctly ordered; conflicting evidence attached; NaN-safe; Phase 1/2 untouched; no allocation tiers.
2. ~~Live validation run~~ done 2026-10-11: full snapshot on real data (Neutral, 42.8); Decision Layer §§1-8 render; all sleeves honestly HOLD/not-rated on the cold-start first decision report; `decision_history.csv` recorded.
3. ~~Operator merge approval~~ granted 2026-10-11; PR #3 merged as c8840b8 (verified byte-identical).

## Phase 4 status (2026-10-11)

Merged to master as `09057b4` (operator-approved; byte-identical verified).
Completion checks:
1. ~~Adversarial review~~ done 2026-10-11 (separate agent, empirical, ~120 assertions): 0 critical, 1 major, 5 minor — all fixed and re-verified on the branch (see CHANGELOG).
2. Live validation — done.
3. Operator merge approval — granted 2026-10-11 ("merge and then begin phase 5").

## Phase 5 status (2026-10-11)

Implemented on branch `muse/phase-5-positions-accountability` (not pushed yet — single-push rule).
Operator approved all 7 design decisions plus guardrails 2026-10-11.
Completion checks:
1. Tests — 57 new tests, full suite 266 passing (4 pre-existing test_news.py date-decay failures also fail on master).
2. Adversarial review — done 2026-10-11 (separate agent, empirical, 201 assertions): 1 major (M1, §1 pointer firing on below-minimum data), 5 minor (M2–M6), 1 observation — M1 fixed on the branch; M2–M6 pending operator scope decision (see CHANGELOG).
3. Live validation — done 2026-10-11: Neutral, flywheel 42.8, journal's first 43 rows recorded (all honestly Not Rated on cold sleeve history, 0 outcomes matured), Track A ran (274 days, exploratory label).
4. Operator merge approval — pending.

## Phase Gate

All five phases are implemented. Phase 5 awaits merge approval.

The full Phase 1-5 instructions are preserved in `DECISION_LAYER_UPGRADE_SPEC.md`. Use that file as the durable source for later-phase requirements after Phase 3 is complete.

## Important Guardrails

- Preserve existing market-data collection, ticker baskets, relative-strength calculations, price-trend analysis,
  news ingestion, theme classification, scoring, reporting, validation, and command-line workflows.
- `TICKER_GROUPS` and existing market-data behavior were not changed by Phase 1; sleeves are a separate analytical layer.
- XLV, QQQ, and SPY remain comparators, not sleeve members (enforced by the loader).
- No allocation tiers or portfolio recommendations until Phase 4, and only with explicit approval.
